Financial Ratios Numans Health Food Holdings Company Limited
Equities
2530
KYG6781U1085
Food Processing
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5300 HKD | -3.64% |
|
0.00% | -14.52% |
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
Profitability | ||||
Return on Assets | - | 18.55 | 29.26 | 15.49 |
Return on Total Capital | - | 28.02 | 38.12 | 17.21 |
Return On Equity % | - | 38.92 | 48.48 | 19.04 |
Return on Common Equity | - | 38.92 | 48.48 | 19.04 |
Margin Analysis | ||||
Gross Profit Margin % | 71.29 | 67.95 | 73.95 | 76.49 |
SG&A Margin | 23.54 | 25.61 | 28.5 | 40.34 |
EBITDA Margin % | 49.28 | 28.39 | 48.27 | 39.83 |
EBITA Margin % | 48.86 | 27.98 | 47.95 | 39.54 |
EBIT Margin % | 48.86 | 27.98 | 47.95 | 39.54 |
Income From Continuing Operations Margin % | 35.45 | 23.83 | 37.36 | 26.99 |
Net Income Margin % | 35.45 | 23.83 | 37.36 | 26.99 |
Net Avail. For Common Margin % | 35.45 | 23.83 | 37.36 | 26.99 |
Normalized Net Income Margin | 28.53 | 16.54 | 28.51 | 25.09 |
Levered Free Cash Flow Margin | - | 22.9 | 7.31 | 24.7 |
Unlevered Free Cash Flow Margin | - | 22.96 | 7.36 | 24.76 |
Asset Turnover | ||||
Asset Turnover | - | 1.06 | 0.98 | 0.63 |
Fixed Assets Turnover | - | 37.23 | 37.87 | 29.9 |
Receivables Turnover (Average Receivables) | - | 5.72 | 6.27 | 4.3 |
Inventory Turnover (Average Inventory) | - | 2.51 | 1.69 | 1 |
Short Term Liquidity | ||||
Current Ratio | 3.25 | 2.4 | 7.77 | 10.63 |
Quick Ratio | 2.48 | 1.73 | 5.89 | 8.04 |
Operating Cash Flow to Current Liabilities | 1.09 | 0.29 | 2.66 | 2.24 |
Days Sales Outstanding (Average Receivables) | - | 63.79 | 58.17 | 85.08 |
Days Outstanding Inventory (Average Inventory) | - | 145.49 | 216.26 | 365.83 |
Long Term Solvency | ||||
Total Debt/Equity | 0.61 | 3.01 | 1.42 | 1.18 |
Total Debt / Total Capital | 0.6 | 2.92 | 1.4 | 1.16 |
LT Debt/Equity | 0.1 | 1.89 | 0.84 | 0.49 |
Long-Term Debt / Total Capital | 0.1 | 1.83 | 0.82 | 0.48 |
Total Liabilities / Total Assets | 29.88 | 38.74 | 12.75 | 9.4 |
EBIT / Interest Expense | 1.41K | 274.01 | 615.99 | 423.62 |
EBITDA / Interest Expense | 1.44K | 286.84 | 630.77 | 439.2 |
(EBITDA - Capex) / Interest Expense | 1.43K | 283.65 | 630.15 | 434.85 |
Total Debt / EBITDA | 0.01 | 0.07 | 0.03 | 0.04 |
Net Debt / EBITDA | -0.9 | -1.72 | -1.23 | -2.03 |
Total Debt / (EBITDA - Capex) | 0.01 | 0.07 | 0.03 | 0.04 |
Net Debt / (EBITDA - Capex) | -0.9 | -1.74 | -1.23 | -2.05 |
Growth Over Prior Year | ||||
Total Revenues, 1 Yr. Growth % | - | 8.79 | 16.13 | -34.94 |
Gross Profit, 1 Yr. Growth % | - | 3.7 | 26.38 | -35.03 |
EBITDA, 1 Yr. Growth % | - | -37.32 | 97.45 | -46.33 |
EBITA, 1 Yr. Growth % | - | -37.7 | 99.03 | -46.35 |
EBIT, 1 Yr. Growth % | - | -37.7 | 99.03 | -46.35 |
Earnings From Cont. Operations, 1 Yr. Growth % | - | -26.86 | 82.06 | -52.99 |
Net Income, 1 Yr. Growth % | - | -26.86 | 82.06 | -52.99 |
Normalized Net Income, 1 Yr. Growth % | - | -36.94 | 100.19 | -46.32 |
Diluted EPS Before Extra, 1 Yr. Growth % | - | - | - | -53 |
Accounts Receivable, 1 Yr. Growth % | - | 14.55 | -1.65 | -8.62 |
Inventory, 1 Yr. Growth % | - | 183.48 | -10.19 | 9.3 |
Net Property, Plant and Equip., 1 Yr. Growth % | - | 80.75 | -22.65 | -11.09 |
Total Assets, 1 Yr. Growth % | - | 39.74 | 16.46 | -11.58 |
Tangible Book Value, 1 Yr. Growth % | - | 20.05 | 66.97 | -8.27 |
Common Equity, 1 Yr. Growth % | - | 22.08 | 65.86 | -8.18 |
Cash From Operations, 1 Yr. Growth % | - | -52.86 | 239.81 | -44.57 |
Capital Expenditures, 1 Yr. Growth % | - | 20.08 | -82.86 | 450.73 |
Levered Free Cash Flow, 1 Yr. Growth % | - | - | -62.9 | 119.71 |
Unlevered Free Cash Flow, 1 Yr. Growth % | - | - | -62.76 | 118.78 |
Compound Annual Growth Rate Over Two Years | ||||
Total Revenues, 2 Yr. CAGR % | - | - | 12.4 | -13.08 |
Gross Profit, 2 Yr. CAGR % | - | - | 14.48 | -7.78 |
EBITDA, 2 Yr. CAGR % | - | - | 11.25 | 2.95 |
EBITA, 2 Yr. CAGR % | - | - | 11.35 | 3.33 |
EBIT, 2 Yr. CAGR % | - | - | 11.35 | 3.33 |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | - | 15.39 | -7.49 |
Net Income, 2 Yr. CAGR % | - | - | 15.39 | -7.49 |
Normalized Net Income, 2 Yr. CAGR % | - | - | 12.36 | 7.05 |
Accounts Receivable, 2 Yr. CAGR % | - | - | 6.14 | -5.2 |
Inventory, 2 Yr. CAGR % | - | - | 59.56 | -0.92 |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | - | 18.24 | -17.07 |
Total Assets, 2 Yr. CAGR % | - | - | 27.57 | 1.48 |
Tangible Book Value, 2 Yr. CAGR % | - | - | 41.58 | 23.76 |
Common Equity, 2 Yr. CAGR % | - | - | 42.3 | 23.4 |
Cash From Operations, 2 Yr. CAGR % | - | - | 26.57 | 37.25 |
Capital Expenditures, 2 Yr. CAGR % | - | - | -54.63 | -2.84 |
Levered Free Cash Flow, 2 Yr. CAGR % | - | - | - | -9.71 |
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | - | - | -9.73 |
Compound Annual Growth Rate Over Three Years | ||||
Total Revenues, 3 Yr. CAGR % | - | - | - | -6.33 |
Gross Profit, 3 Yr. CAGR % | - | - | - | -4.1 |
EBITDA, 3 Yr. CAGR % | - | - | - | -12.75 |
EBITA, 3 Yr. CAGR % | - | - | - | -12.71 |
EBIT, 3 Yr. CAGR % | - | - | - | -12.71 |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | - | -14.46 |
Net Income, 3 Yr. CAGR % | - | - | - | -14.46 |
Normalized Net Income, 3 Yr. CAGR % | - | - | - | -10.26 |
Accounts Receivable, 3 Yr. CAGR % | - | - | - | 0.97 |
Inventory, 3 Yr. CAGR % | - | - | - | 40.66 |
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | - | 7.52 |
Total Assets, 3 Yr. CAGR % | - | - | - | 12.9 |
Tangible Book Value, 3 Yr. CAGR % | - | - | - | 22.51 |
Common Equity, 3 Yr. CAGR % | - | - | - | 22.96 |
Cash From Operations, 3 Yr. CAGR % | - | - | - | -3.88 |
Capital Expenditures, 3 Yr. CAGR % | - | - | - | 4.27 |
Select your edition
All financial news and data tailored to specific country editions
















